$DXCM

AI 分析

生成於 May 11, 2026

AI Score
66/ 100
Hold$DXCM

DexCom Inc.

$DXCMNASDAQHealthcareLarge-Cap

Dexcom develops and markets continuous glucose monitoring systems for diabetes management.

Market Cap
$32.0B
Revenue (TTM)
$3.9B
+12.0%
Net Income (TTM)
$0.5B
+20.0%
EPS (TTM)
$1.25
P/E Ratio
80.0
Dividend Yield
0.0%
52-Week Range
$62-$140
Beta
1.15
Dimension Scores
Fundamental
62
Technical
58
Sentiment
68
Risk / Reward
60
Momentum
68
FundTechSentRiskMome
Financial Health
Profitability
67moderate
Growth
71moderate
Liquidity
68strong
Solvency
64strong
Efficiency
60moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $DXCM

Free · No credit card required

免責聲明: AI 生成的分析僅供教育參考,不構成投資建議。請始終諮詢合格的理財顧問。

探索更多

用 AI 分析任意股票

獲取涵蓋基本面、技術面、情緒面、風險評估和投資論點的結構化研究報告——約 60 秒完成。